New-Onset Type 1 Diabetes Mellitus After Treatment With Nivolumab for Melanoma

A 67-year-old female taking Nivolumab for melanoma developed a hyperglycemic emergency requiring hospital admission. She was referred to our endocrinology clinic post-discharge where she was diagnosed with new-onset Type 1 diabetes mellitus. Severe hyperglycemia and immune-mediated diabetes mellitus...

Descripción completa

Detalles Bibliográficos
Autores principales: Baroud, Sarah, Mirza, Lubna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Endocrinology/Diabetes/Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580131/
https://www.ncbi.nlm.nih.gov/pubmed/34786258
http://dx.doi.org/10.7759/cureus.18679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8580131/
https://www.ncbi.nlm.nih.gov/pubmed/34786258
http://dx.doi.org/10.7759/cureus.18679

Ejemplares similares